Abstract
Background
This study examined the association between race/ethnicity and health insurance payer type with pediatric opioid and non-opioid ordering in an inpatient hospital setting.
Methods
Cross-sectional inpatient encounter data from June 2013 to June 2018 was retrieved from a pediatric children’s hospital in Southern California (N = 55,944), and statistical analyses were performed to determine associations with opioid ordering.
Results
There was a significant main effect of race/ethnicity on opioid and non-opioid orders. Physicians ordered significantly fewer opioid medications, but a greater number of non-opioid medications, for non-Hispanic African American children than non-Hispanic Asian, Hispanic/Latinx, and non-Hispanic White pediatric patients. There was also a main effect of health insurance payer type on non-opioid orders. Patients with government-sponsored plans (e.g., Medi-Cal, Medicare) received fewer non-opioid prescriptions compared with patients with both HMO and PPO coverage. Additionally, there was a significant race/ethnicity by insurance interaction on opioid orders. Non-Hispanic White patients with “other” insurance coverage received the greatest number of opioid orders. In non-Hispanic African American patients, children with PPO coverage received fewer opioids than those with government-sponsored and HMO insurance. For non-Hispanic Asian patients, children with PPO were prescribed more opioids than those with government-sponsored and HMO coverage.
Conclusion
Findings suggest that the relationship between race/ethnicity, insurance type, and physician decisions opioid prescribing is complex and multifaceted. Given that consistency in opioid prescribing should be seen regardless of patient background characteristics, future studies should continue to assess and monitor unequitable differences in care.
Similar content being viewed by others
References
Jones MR, Novitch MB, Sarrafpour S, Ehrhardt KP, Scott BB, Orhurhu V, et al. Government legislation in response to the opioid epidemic. Curr Pain Headache Rep. 2019;23(6):40. https://doi.org/10.1007/s11916-019-0781-1.
Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA. 2013;309(7):657–9.
Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies: tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–6. https://doi.org/10.1056/NEJMp1404181.
Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019;43(3):123–31. https://doi.org/10.1053/j.semperi.2019.01.001.
Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012. JAMA Pediatr. 2016;170(12):1195–201. https://doi.org/10.1001/jamapediatrics.2016.2154.
Gaither JR, Shabanova V, Leventhal JM. US National Trends in pediatric deaths from prescription and illicit opioids, 1999-2016. JAMA Netw Open. 2018;1(8):e186558. https://doi.org/10.1001/jamanetworkopen.2018.6558.
Tomaszewski DM, Arbuckle C, Yang S, Linstead E. Trends in opioid use in pediatric patients in US emergency departments from 2006 to 2015. JAMA Netw Open. 2018;1(8):e186161. https://doi.org/10.1001/jamanetworkopen.2018.6161.
Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on drug use and health. Substance Abuse and Mental Health Services Administration. Published September 2017. https://www.samhsa.gov/data/
McCabe SE, West BT, Veliz P, McCabe VV, Stoddard SA, Boyd CJ. Trends in medical and nonmedical use of prescription opioids among US adolescents. Pediatrics. 2017;139(4):e20162387.
Miech R, Johnston L, O’Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. PEDIATRICS. 2015;136(5):1169–77. https://doi.org/10.1542/peds.2015-1364.
Harbaugh CM, Lee JS, Hu HM, McCabe SE, Voepel-Lewis T, Englesbe MJ, et al. Persistent opioid use among pediatric patients after surgery. Pediatrics. 2018;141(1):e20172439. https://doi.org/10.1542/peds.2017-2439.
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315(15):1624–45. https://doi.org/10.1001/jama.2016.1464.
Zhu A, Benzon HA, Anderson TA. Evidence for the efficacy of systemic opioid-sparing analgesics in pediatric surgical populations: a systematic review. Anesth Analg. 2017;125(5):1569–87. https://doi.org/10.1213/ANE.0000000000002434.
Wong I, St John-Green C, Walker SM. Opioid-sparing effects of perioperative paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs) in children. Lonnqvist P-A, ed. Paediatr Anaesth 2013;23(6):475–495. doi:https://doi.org/10.1111/pan.12163.
Schug SA. The role of COX-2 inhibitors in the treatment of postoperative pain. J Cardiovasc Pharmacol. 2006;47(Supplement 1):S82–6. https://doi.org/10.1097/00005344-200605001-00015.
Yang J, Bauer BA, Wahner-Roedler DL, Chon TY, Xiao L. The modified WHO analgesic ladder: is it appropriate for chronic non-cancer pain? JPR. 2020;13:411–7. https://doi.org/10.2147/JPR.S244173.
Edlund MJ, Martin BC, Russo JE, Devries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557–64. https://doi.org/10.1097/AJP.0000000000000021.
Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009;10(12):1187–204. https://doi.org/10.1016/j.jpain.2009.10.002.
Tamayo-Sarver JH, Hinze SW, Cydulka RK, Baker DW. Racial and ethnic disparities in emergency department analgesic prescription. Am J Public Health. 2003;93(12):2067–73. https://doi.org/10.2105/AJPH.93.12.2067.
Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299(1):70–8. https://doi.org/10.1001/jama.2007.64.
Singhal A, Tien Y-Y, Hsia RY. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. In: Seedat S, editor. PLoS ONE, vol. 11; 2016. p. e0159224. https://doi.org/10.1371/journal.pone.0159224.
Dickason RM, Chauhan V, Mor A, Ibler E, Kuehnle S, Mahoney D, et al. Racial differences in opiate administration for pain relief at an academic emergency department. WestJEM. 2015;16(3):372–80. https://doi.org/10.5811/westjem.2015.3.23893.
Goyal MK, Kuppermann N, Cleary SD, Teach SJ, Chamberlain JM. Racial disparities in pain management of children with appendicitis in emergency departments. JAMA Pediatr. 2015;169(11):996–1002. https://doi.org/10.1001/jamapediatrics.2015.1915.
Jimenez N, Seidel K, Martin LD, Rivara FP, Lynn AM. Perioperative analgesic treatment in Latino and non-Latino pediatric patients. J Health Care Poor Underserved. 2010;21(1):229–36. https://doi.org/10.1353/hpu.0.0236.
Sadhasivam S, Chidambaran V, Ngamprasertwong P, Esslinger HR, Prows C, Zhang X, et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. PEDIATRICS. 2012;129(5):832–8. https://doi.org/10.1542/peds.2011-2607.
Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM. Controlled substance prescribing patterns — prescription behavior surveillance system, Eight States, 2013. MMWR Surveill Summ. 2015;64(9):1–14. https://doi.org/10.15585/mmwr.ss6409a1.
Benefits.gov. California Medicaid. Benefits.gov. Accessed September 8, 2020. https://www.benefits.gov/benefit/1620
Arpey NC, Gaglioti AH, Rosenbaum ME. How socioeconomic status affects patient perceptions of health care: a qualitative study. J Prim Care Community Health. 2017;8(3):169–75. https://doi.org/10.1177/2150131917697439.
Becker G, Newsom E. Socioeconomic status and dissatisfaction with health care among chronically ill African Americans. Am J Public Health. 2003;93(5):742–8. https://doi.org/10.2105/AJPH.93.5.742.
Waldrop LD, King JJ, Mayfield J, et al. The effect of lower socioeconomic status insurance on outcomes after primary shoulder arthroplasty. J Shoulder Elb Surg. 2018;27(6):S35–42. https://doi.org/10.1016/j.jse.2018.01.002.
Huttin C. The role of different types of health insurance on access and utilization of antihypertensive drugs: an empirical study in a US hypertensive population. Dis Manag Health Out. 2002;10(7):419–30. https://doi.org/10.2165/00115677-200210070-00003.
Ehwerhemuepha L, Gasperino G, Bischoff N, Taraman S, Chang A, Feaster W. HealtheDataLab – a cloud computing solution for data science and advanced analytics in healthcare with application to predicting multi-center pediatric readmissions. BMC Med Inform Decis Mak. 2020;20(1):1–12. https://doi.org/10.1186/s12911-020-01153-7.
Chung CP, Callahan ST, Cooper WO, Dupont WD, Murray KT, Franklin AD, et al. Outpatient opioid prescriptions for children and opioid-related adverse events. Pediatrics. 2018;142(2):e20172156. https://doi.org/10.1542/peds.2017-2156.
Richardson LP, Fan MY, McCarty CA, et al. Trends in the prescription of opioids for adolescents with non-cancer pain. Gen Hosp Psychiatry. 2011;33(5):423–8. https://doi.org/10.1016/j.genhosppsych.2011.04.009.
Ehwerhemuepha L, Schultz S, Feaster W. Clinical and psychosocial factors associated with patient experience in pediatrics. Clin Pediatr (Phila). 2018;57(8):937–44. https://doi.org/10.1177/0009922817737078.
Voepel-Lewis T, Merkel S, Tait AR, Trzcinka A, Malviya S. The reliability and validity of the face, legs, activity, cry, consolability observational tool as a measure of pain in children with cognitive impairment. Anesth Analg. 2002;95(5):1224–9. https://doi.org/10.1097/00000539-200211000-00020.
Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The faces pain scale – revised: toward a common metric in pediatric pain measurement. Pain. 2001;93(2):173–83. https://doi.org/10.1016/S0304-3959(01)00314-1.
Miró J, Castarlenas E, Huguet A. Evidence for the use of a numerical rating scale to assess the intensity of pediatric pain. Eur J Pain. 2009;13(10):1089–95. https://doi.org/10.1016/j.ejpain.2009.07.002.
Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol. 2008;28:55–60. https://doi.org/10.1097/00000539-200211000-00020.
Sills MR, Hall M, Cutler GJ, Colvin JD, Gottlieb LM, Macy ML, et al. Adding social determinant data changes children’s hospitals’ readmissions performance. J Pediatr. 2017;186:150–7.
Ehwerhemuepha L, Finn S, Rothman M, Rakovski C, Feaster W. A novel model for enhanced prediction and understanding of unplanned 30-day pediatric readmission. Hosp Pediatr. 2018;8(9):578–87. https://doi.org/10.1542/hpeds.2017-0220.
Ehwerhemuepha L, Pugh K, Grant A, Taraman S, Chang A, Rakovski C, et al. A statistical-learning model for unplanned 7-day readmission in pediatrics. Hosp Pediatr. 2020;10(1):43–51.
Delaplain PT, Guner YS, Feaster W, Gholizadeh M, Reyna T, Ehwerhemuepha L. Prediction of 7-day readmission risk for pediatric trauma patients. J Surg Res. 2020;253:254–61.
Meyers LS, Gamst GC, Guarino AJ. Applied multivariate research: design and interpretation. 2nd ed. Sage Publications, Inc; 2013.
Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36(1):559–74. https://doi.org/10.1146/annurev-publhealth-031914-122957.
Bonar EE, Coughlin L, Roche JS, Philyaw-Kotov ML, Bixler EA, Sinelnikov S, et al. Prescription opioid misuse among adolescents and emerging adults in the United States: a scoping review. Prev Med. 2020;132:105972. https://doi.org/10.1016/j.ypmed.2019.105972.
McCabe SE, Veliz P, Schulenberg JE. Adolescent context of exposure to prescription opioids and substance use disorder symptoms at age 35: a national longitudinal study. PAIN. 2016;157(10):2173–8. https://doi.org/10.1097/j.pain.0000000000000624.
Edwards RR, Fillingim RB. Ethnic differences in thermal pain responses. Psychosom Med. 1999;61(3):346–54. https://doi.org/10.1097/00006842-199905000-00014.
Campbell CM, Edwards RR, Fillingim RB. Ethnic differences in responses to multiple experimental pain stimuli. Pain. 2005;113(1):20–6. https://doi.org/10.1016/j.pain.2004.08.013.
Fortier MA, Anderson CT, Kain ZN. Ethnicity matters in the assessment and treatment of children’s pain. Pediatrics. 2009;124(1):378–80.
Donaldson CD, Nakawaki B, Crano WD. Variations in parental monitoring and predictions of adolescent prescription opioid and stimulant misuse. Addict Behav. 2015;45:14–21. https://doi.org/10.1016/j.addbeh.2015.01.022.
United States Census Bureau. U.S. Census Bureau QuickFacts: California . Retrieved from https://www.census.gov/quickfacts/CA
Tait RC, Chibnall JT, Kalauokalani D. Provider judgments of patients in pain: seeking symptom certainty. Pain Med. 2009;10(1):11–34. https://doi.org/10.1111/j.1526-4637.2008.00527.x.
Blair IV, Havranek EP, Price DW, Hanratty R, Fairclough DL, Farley T, et al. Assessment of biases against Latinos and African Americans among primary care providers and community members. Am J Public Health. 2013;103(1):92–8. https://doi.org/10.2105/AJPH.2012.300812.
Street RL Jr, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005;43(10):960–9.
Mossey JM. Defining racial and ethnic disparities in pain management. Clin Orthop Relat Res. 2011;469(7):1859–70. https://doi.org/10.1007/s11999-011-1770-9.
Acknowledgments
We would like to acknowledge the Kay Family Foundation for their generous support of this work.
Funding
This project was supported by the Kay Family Foundation Data Analytics grant at Chapman University.
Author information
Authors and Affiliations
Contributions
Dr. Louis Ehwerhemuepha: This author contributed to the conception and design of the study and acquisition of the data and reviewed and revised the article for intellectual content and drafted the discussion.
Dr. Candice D. Donaldson: This author conducted the statistical analysis, drafted the method and results, and reviewed and revised the article for intellectual content.
Dr. Zeev N. Kain: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Ms. Vivian Luong: This author drafted the introduction and reviewed and revised the manuscript for intellectual content.
Dr. Michelle A. Fortier: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. William Feaster: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. Michael Weiss: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. Daniel Tomaszewski: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. Sun Yang: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. Michael Phan: This author contributed to the interpretation of data and reviewed and revised the article for intellectual content.
Dr. Brooke N. Jenkins: This author contributed to the conception and design of the study and acquisition of the data and reviewed and revised the article for intellectual content.
All figures were created on Microsoft Excel and reviewed by all authors.
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Zeev N. Kain is a speaker for Covidien and a member of Edwards Life Sciences and Huron Consulting.
Code Availability
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ehwerhemuepha, L., Donaldson, C.D., Kain, Z.N. et al. Race, Ethnicity, and Insurance: the Association with Opioid Use in a Pediatric Hospital Setting. J. Racial and Ethnic Health Disparities 8, 1232–1241 (2021). https://doi.org/10.1007/s40615-020-00882-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40615-020-00882-9